scispace - formally typeset
M

Mohammed Ahmed Rashid

Researcher at University College London

Publications -  56
Citations -  646

Mohammed Ahmed Rashid is an academic researcher from University College London. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 9, co-authored 37 publications receiving 537 citations. Previous affiliations of Mohammed Ahmed Rashid include Royal Free Hospital & University of Cambridge.

Papers
More filters
Journal ArticleDOI

Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors

TL;DR: This is the first systematic analysis showing EpCAM expression and CTC detection in NETs and seems to be associated with progressive disease and may provide useful prognostic information given the variable survival rates in these tumors.
Journal ArticleDOI

Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer

TL;DR: The authors' biomarker algorithm provides novel insights into the cell-cycle state of dynamic tumour cell populations in vivo, of major prognostic significance and may impact on individualised therapeutic decisions.
Journal ArticleDOI

Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma

TL;DR: Findings show that Cdc7 kinase predicts survival and is a potent anticancer target in epithelial ovarian carcinoma, highlighting its potential as a predictor of susceptibility to small molecule kinase inhibitors currently in development.
Journal ArticleDOI

Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging

TL;DR: Radiolabelled DARPin (HE)3-G3 is a versatile radioligand with potential to allow the acquisition of whole-body HER2 scans on the day of administration and demonstrated that radioactivity from 111In-(HE) 3-G 3 was better maintained in tumours and cleared faster from serum thanRadioactivity from 125I-(HE), achieving superior tumour-to-blood ratios.
Journal ArticleDOI

Targeting DNA Replication before it Starts: Cdc7 as a Therapeutic Target in p53-Mutant Breast Cancers

TL;DR: In this article, the cell-cycle protein Cdc7 regulates S phase by promoting DNA replication, which is an attractive therapeutic target for triple-receptor negative and Her2-overexpressing breast cancer.